- Market Realist•6 hours ago
Wall Street analysts estimate that AstraZeneca’s (AZN) top line will rise 8.0% to ~$4,742 million in 1Q17.
- Market Realist•8 hours ago
AstraZeneca’s (AZN) revenues are expected to fall 12.2% to $5.4 billion during 1Q17 as compared to $6.1 billion for 1Q16.
- Market Realist•10 hours ago
Analysts estimate AstraZeneca will post EPS (or earnings per share) of $0.40 and revenues of $5.4 billion in 1Q17.
AZN : Summary for Astrazeneca PLC Common Stock - Yahoo Finance
AstraZeneca PLC (AZN)
NYSE - NYSE Delayed Price. Currency in USD
Add to watchlist
|Day's Range||30.47 - 30.74|
|52 Week Range||25.55 - 35.04|
Trade prices are not sourced from all markets
|PE Ratio (TTM)||22.16|
|Dividend & Yield||1.90 (6.30%)|
|1y Target Est||N/A|